The largest drug
discovery company
in the CEE region


Your integrated drug
discovery partner of choice


Developing breakthrough
therapies in oncology


Delivering comprehensive
research solutions to biotech
and pharma


News See all

Selvita presents new data from SEL120 program during Leukemia…

Krakow, Poland – 03 October – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines...

Selvita presents at the 18th Annual Biotech in Europe…

Krakow, Poland – 02 October – Selvita will participate and present at the upcoming 18th Annual Biotech in Europe Forum, which...

Selvita participates as a panelist at the Charting Poland’s…

Krakow, Poland - 24 September – Selvita will participate as a panelist at the "Charting Poland's Future Event: Spotlight on Growth...

Selvita presents and exhibits at the upcoming Medicinal Chemistry…

Krakow, Poland – 13 September 2018 – Selvita will present and exhibit at the upcoming Medicinal Chemistry Summit: USA, which...

Selvita demonstrates dynamic and strong revenue growth in H1…

Krakow, Poland – 11 September 2018 – Selvita, one of the largest drug discovery companies in Europe, has recently published...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.


Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.


Research and Development

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.


Investor Relations SLV +0,00PLN -1,82%

Share price 2018-10-16 17:04:05

54,00 PLN More


We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.